dacarbazine and Anaplastic Oligodendroglioma

dacarbazine has been researched along with Anaplastic Oligodendroglioma in 83 studies

Research

Studies (83)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (2.41)	18.2507
2000's	37 (44.58)	29.6817
2010's	43 (51.81)	24.3611
2020's	1 (1.20)	2.80

Authors

Authors	Studies
Cloughesy, TF; Lassman, AB	1
Alattar, AA; Ali, MA; Brandel, MG; Carroll, KT; Carter, B; Chen, CC; Hirshman, B; Lanman, T; Lochte, B	1
Ohara, K; Sasaki, H; Tamura, R; Tokuda, Y; Yoshida, K	1
Abrey, LE; Brennan, CW; Briggs, S; Cairncross, JG; Chakravarty, D; DeAngelis, LM; Faivre, G; Forsyth, P; Gao, J; Grimm, S; Huse, JT; Jonsson, P; Kaley, T; Louis, DN; Martinez, NL; Matasar, M; Mehta, J; Mohile, NA; Moskowitz, C; Nimer, SD; Omuro, A; Paleologos, N; Panageas, KS; Raizer, J; Sauter, CS; Schultz, N; Terziev, R; Thomas, AA	1
Friedman, GK; Li, R; Perry, A; Reddy, AT; Singh, S; Solomon, DA; Sorge, C	1
Abraham Koshy, A; Kumar A, A	1
Drappatz, J; Lieberman, F	1
Amano, T; Fujioka, Y; Hata, N; Iwaki, T; Mizoguchi, M; Murata, H; Nakamizo, A; Sasaki, T; Suzuki, SO; Yoshimoto, K	1
Anderson, MD; Gilbert, MR	1
Asano, K; Ito, E; Katayama, K; Komori, T; Ohkuma, H; Sasaki, S; Sato, T; Terui, K	1
Chen, HJ; Hsu, CT; Huang, PH; Huang, SH; Lu, K; Sha, SJ; Wu, HP	1
Borisova, LM; Ermakova, KV; Kiselyova, MP; Kubasova, IY; Luk'yanets, EA; Meerovich, GA; Oborotova, NA; Smirnova, ZS	1
Cairncross, JG; Luchman, HA; Lun, XQ; Nguyen, SA; Robbins, SM; Senger, DL; Stechishin, OD; Weiss, S	1
Ahluwalia, MS; Brewer, C; Chamberlain, MC; Dahiya, S; Elson, P; Fisher, PG; Hashemi-Sadraei, N; Newton, HB; Pannullo, S; Peereboom, DM; Prayson, R; Schiff, D; Wood, L; Xie, H	1
Levin, VA	1
Rinne, ML; Wen, PY	1
Agarwal, A; Churi, S; Epari, S; Goda, JS; Gupta, T; Jalali, R; Lewis, S; Moiyadi, A; Padmavati, A; Shetty, P	1
Brachman, DG; Giannini, C; Hu, C; Jenkins, RB; Laack, NN; Macdonald, DR; Mehta, MP; Peereboom, DM; Shrieve, DC; Souhami, L; Suh, JH; Vogelbaum, MA	1
Cachia, D; Cykowski, MD; Jalali, A; Langford, LA; Li, J; Penas-Prado, M; Shah, K; Strickland, BA; Weinberg, JS	1
Lassman, AB	1
Bromberg, JE; Buckner, J; Van Den Bent, MJ	1
Cantero, D; Hernandez-Lain, A; Hilario, A; Perez-Nuñez, A; Ramos, A; Sepulveda, JM	1
Cahill, DP; Chi, AS; Larvie, M; Louis, DN	1
Butowski, N; Chang, SM; Fedoroff, A; Lamborn, KR; Liu, R; Page, M; Polley, MY; Prados, M; Rabbitt, J; Solheim, K	1
Berkey, B; Biggs, C; Blumenthal, DT; Brown, P; Giannini, C; Herman, J; Jenkins, R; Macdonald, D; Mehta, M; Peereboom, D; Schultz, C; Suh, JH; Vogelbaum, MA	1
Anderson, J; Avedissian, R; Croteau, D; Doyle, T; Gutierrez, J; Hasselbach, L; Margolis, J; Mikkelsen, T; Paleologos, N; Schultz, L	1
Fukushima, T; Inoue, T; Komatsu, F; Ohmura, T; Ohta, M; Oshiro, S; Sakamoto, S; Tsugu, H	1
Chaskis, C; Michotte, A; Neyns, B; Sadones, J; Veld, PI	1
Baron, MH; Bauchet, L; Bernier, V; Capelle, L; Duffau, H; Fontaine, D; Guyotat, J; Mandonnet, E; Pallud, J; Peruzzi, P; Taillandier, L	1
Buffone, E; Ghimenton, C; Iuzzolino, P; Masotto, B; Moretto, G; Musso, AM; Ottaviani, S; Passarin, MG; Pedersini, R; Rudà, R; Soffietti, R; Vattemi, E	1
Delashaw, JB; Doolittle, ND; Gahramanov, S; Guillaume, DJ; Hedrick, NA; Neuwelt, EA	1
Bontempi, G; Bruyère, C; Decaestecker, C; Dubois, J; Haibe-Kains, B; Kiss, R; Lamoral-Theys, D; Le Calvé, B; Le Mercier, M; Lefranc, F; Rynkowski, MA	1
Cho, KH; Kim, JY; Kim, TH; Lee, DH; Lee, SH; Moon, SH; Pyo, HR; Shin, KH; Shin, SH; Yoo, H; Yoon, M	1
Algar, E; Benson, A; Cher, L; Dowling, A; Gan, HK; Kalnins, R; Rosenthal, MA; Wong, N; Woods, AM	1
Carpentier, C; Dehais, C; del Rio, MS; Delattre, JY; Ducray, F; Hoang-Xuan, K; Idbaih, A; Kaloshi, G; Laigle-Donadey, F; Mokhtari, K; Omuro, A; Psimaras, D; Sanson, M; Taillibert, S	1
Auvergne, R; Ayers-Ringler, J; Berger, MS; Bergers, G; Goldenberg, DD; Goldman, SA; Itsara, M; McKnight, TR; Nguyen, KN; Nishiyama, A; Persson, AI; Petritsch, C; Sim, FJ; Stallcup, WB; Swartling, FJ; Vandenberg, SR; Weiss, WA; Yakovenko, S	1
Lou, X; Qiao, G; Wang, F	1
Abrey, LE; Aldape, KD; Ashby, LS; Cairncross, JG; Chamberlain, MC; Cloughesy, TF; DeAngelis, LM; Eichler, AF; Fisher, BJ; Green, RM; Iwamoto, FM; Jhanwar, SC; Kamar, FG; Lassman, AB; Ligon, KL; Louis, DN; Mason, WP; Paleologos, NA; Panageas, KS; Rivera, AL; Robins, HI; Rocque, BG; Roldán, GB; Rosenblum, MK; Schiff, D; Weaver, SA; Wen, PY	1
Liu, B; Qu, L; Tao, H; Wu, Y	1
Ara, J; Chadarévian, JP; Faerber, EN; Grant, ML; Halligan, GE; Katsetos, CD; Legido, A; Morrissette, JD; Piatt, JH	1
Bady, P; Besuchet Schmutz, N; Diserens, AC; Gorlia, T; Hamou, MF; Hartmann, C; Hegi, ME; Janzer, RC; Kouwenhoven, MC; Lambiv, WL; Martinet, D; Mason, WP; Mirimanoff, RO; Mokhtari, K; Stupp, R; van den Bent, MJ; von Deimling, A; Weller, M; Wesseling, P	1
Coan, A; Desjardins, A; Friedman, HS; Gururangan, S; Herndon, JE; Janney, D; Lipp, ES; McLendon, R; Peters, KB; Reardon, DA; Rich, JN; Sathornsumetee, S; Vredenburgh, JJ	1
Bertoni, F; Biti, G; Buglione, M; Cipressi, S; Dall'oglio, S; de Renzis, C; Detti, B; Fariselli, L; Fusco, V; Krengli, M; Lioce, M; Magrini, SM; Mantovani, C; Masini, L; Muto, P; Parisi, S; Pirtoli, L; Ricardi, U; Rubino, G; Saieva, C; Santoni, R; Scoccianti, S; Sotti, G; Tombolini, V	1
Abrey, LE; Aldape, KD; Ashby, LS; Cairncross, JG; Chamberlain, MC; Cloughesy, TF; Deangelis, LM; Eichler, AF; Fisher, BJ; Green, RM; Iwamoto, FM; Jhanwar, SC; Kamar, FG; Lassman, AB; Ligon, KL; Louis, DN; Mason, WP; Paleologos, NA; Panageas, KS; Rivera, AL; Robins, HI; Rocque, BG; Roldán Urgoiti, GB; Rosenblum, MK; Schiff, D; Weaver, SA; Wen, PY	1
Houkin, K; Kamoshima, Y; Kobayashi, H; Motegi, H; Murata, J; Tanino, M; Terasaka, S; Yamaguchi, S	1
Homicsko, K; Hottinger, AF; Lhermitte, B; Negretti, L; Stupp, R	1
Hewer, E; Kappeler, A; Reinert, MM; Vajtai, I; Vassella, E	1
Alacacioglu, A; Canpolat, S; Coskun, A; Karatas, A; Oztekin, O; Postaci, H; Sop, G; Unal, S; Yurt, A	1
Baayen, HC; Barkhof, F; Boogerd, W; Castelijns, JA; Elkhuizen, PH; Heimans, JJ; Postma, TJ; Uitdehaag, BM; Vos, MJ	1
Baron, B; Boogerd, W; Bravo Marques, J; Chinot, O; De Beule, N; Kros, JM; Taphoorn, MJ; van den Bent, MJ; van der Rijt, CC; Vecht, CJ	1
Cairncross, JG; Chinot, OL; van den Bent, M	1
Barnett, G; Chahlavi, A; Elson, P; Kanner, A; Peereboom, D; Staugaitis, SM	1
Allgeier, A; Brandes, AA; Chinot, O; Frenay, M; Gorlia, T; Kros, JM; Menten, J; Stupp, R; Taphoorn, MJ; van den Bent, MJ; van der Rijt, CC; Vecht, ChJ	1
Maltoni, S; Messori, A; Pelagotti, F; Trippoli, S; Vacca, F; Vaiani, M	1
Engelhard, HH; Mundt, A; Stelea, A	1
Bilbao, JM; Morrison, T; Perry, JR; Yang, G	1
Bourg, V; Chanalet, S; Chatel, M; Fontaine, D; Frenay, M; Lebrun, C; Lonjon, M; Michiels, JF; Paquis, P; Ramaioli, A; Vandenbos, F	1
Aguirre-Cruz, L; Crinière, E; Delattre, JY; Duprez, A; Golmard, JL; Kujas, M; Leuraud, P; Marie, Y; Medioni, J; Poupon, MF; Sanson, M; Taillandier, L	1
Carpentier, A; Cartalat-Carel, S; Chinot, O; Cougnard, J; Delattre, JY; Djafari, L; Duffau, H; Gervais, H; Hoang-Xuan, K; Honnorat, J; Laigle, F; Mokhtari, K; Napolitano, M; Sanson, M; Taillandier, L; Taillibert, S	1
Gomori, JM; Levin, N; Siegal, T	1
Broët, P; Capelle, L; Carpentier, AF; Cornu, P; Crinière, E; Delattre, JY; Duffau, H; Hoang-Xuan, K; Kujas, M; Laigle, F; Lejeune, J; Marie, Y; Mokhtari, K; Polivka, M; Sanson, M; Simon, JM; Taillibert, S	1
Allgeier, A; Brandes, AA; Enting, RH; Frenay, M; Kros, JM; Menten, J; Stege, EB; Taphoorn, MJ; Tosoni, A; Triebels, VH; van den Bent, MJ; van Heuvel, I	1
Carpentier, AF	1
Byrne, TN	1
Franz, M; Grosu, AL; Gumprecht, H; Molls, M; Nieder, C; Piert, M; Schwaiger, M; Stärk, S; Thamm, R; Weber, WA	1
Abrey, LE; Demopoulos, A; Franceschi, E; Lassman, AB; Nolan, C; Omuro, AM	1
Bokstein, F; Fellig, Y; Fuchs, D; Lavon, I; Levin, N; Siegal, T; Zelikovitsh, B	1
Baehring, J; Ballen, KK; Berliner, N; Henson, JW; Kracher, J; Lacy, J; Noronha, V	1
Bokstein, F; Lavon, I; Siegal, T; Taliansky-Aronov, A	1
Glass, J; Nei, M; Ngo, L	1
Biemond-ter Stege, EM; Brandes, AA; French, PJ; Graveland, WJ; Kouwenhoven, MC; Kros, JM; Taphoorn, MJ; van den Bent, MJ	1
Bertorelle, R; Blatt, V; Bonaldi, L; Brandes, AA; Cavallo, G; Ermani, M; Franceschi, E; Gardiman, M; Ghimenton, C; Iuzzolino, P; Pession, A; Reni, M; Tosoni, A	1
Chakravarti, A; Mehta, MP; Siker, ML	1
Laigle-Donadey, F; Sanson, M	1
Brandsma, D; van den Bent, MJ	1
Katayama, Y; Yoshino, A	1
Chamberlain, MC; Glantz, MJ	1
Darling, JL; Sankar, A; Thomas, DG	1
Burton, E; Prados, M	1
Barrie, M; Braguer, D; Chinot, OL; Dufour, H; Figarella-Branger, D; Grisoli, F; Honore, S; Martin, PM; Muracciole, X	1
Brandes, AA; Carpentier, AF; Eskens, FA; Keime-Guibert, F; Kros, JM; Taphoorn, MJ; van den Bent, MJ	1
Chinot, O	1

Reviews

20 review(s) available for dacarbazine and Anaplastic Oligodendroglioma

Article	Year
Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature. Pediatric blood & cancer, 2017, Volume: 64, Issue:12 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Child; Dacarbazine; Humans; Isocitrate Dehydrogenase; Male; Oligodendroglioma; Temozolomide	2017
Regression of Recurrent High-Grade Glioma with Temozolomide, Dexamethasone, and Levetiracetam: Case Report and Review of the Literature. World neurosurgery, 2017, Volume: 108 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Corpus Callosum; Craniotomy; Dacarbazine; Decompression, Surgical; Dexamethasone; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Oligodendroglioma; Piracetam; Remission Induction; Temozolomide; Tomography, X-Ray Computed	2017
Treatment recommendations for anaplastic oligodendrogliomas that are codeleted. Oncology (Williston Park, N.Y.), 2013, Volume: 27, Issue:4 Topics: Brain Neoplasms; Dacarbazine; Humans; Isocitrate Dehydrogenase; Mutation; Oligodendroglioma; Temozolomide	2013
Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen? CNS oncology, 2015, Volume: 4, Issue:5 Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Dacarbazine; Humans; Lomustine; Oligodendroglioma; Procarbazine; Temozolomide; Treatment Outcome; Vincristine	2015
Low-grade and anaplastic oligodendroglioma. Handbook of clinical neurology, 2016, Volume: 134 Topics: Antineoplastic Agents; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Isocitrate Dehydrogenase; Mutation; Oligodendroglioma; Procarbazine; Temozolomide; Tumor Suppressor Proteins; Vincristine	2016
Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas. International journal of radiation oncology, biology, physics, 2010, Oct-01, Volume: 78, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Dacarbazine; Female; Humans; Male; Middle Aged; Oligodendroglioma; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Temozolomide; Tumor Burden; Young Adult	2010
Extracranial skeletal metastasis in anaplastic oligodendroglioma: case report and review of the literature. The Journal of international medical research, 2011, Volume: 39, Issue:3 Topics: Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Dacarbazine; Femur; Humans; Magnetic Resonance Imaging; Male; Oligodendroglioma; Temozolomide	2011
Cerebellar gliomatosis in a toddler: case report of a challenging condition and review of the literature. Journal of child neurology, 2012, Volume: 27, Issue:4 Topics: Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Cerebellum; Child, Preschool; Dacarbazine; Humans; Intermediate Filament Proteins; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neoplasms, Neuroepithelial; Nerve Tissue Proteins; Nestin; Neurosurgery; Oligodendroglia; Oligodendroglioma; Receptor, Platelet-Derived Growth Factor alpha; Temozolomide; Tumor Cells, Cultured; Vimentin	2012
Recent developments in the molecular characterization and treatment of oligodendroglial tumors. Neuro-oncology, 2003, Volume: 5, Issue:2 Topics: Animals; Astrocytoma; Clinical Trials as Topic; Dacarbazine; Humans; Oligodendroglioma; Temozolomide	2003
Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis. Surgical neurology, 2003, Volume: 60, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Diagnosis, Differential; Humans; Incidence; Lomustine; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Temozolomide; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine	2003
Bony metastases of anaplastic oligodendroglioma respond to temozolomide. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2004, Volume: 31, Issue:1 Topics: Adult; Bone Neoplasms; Dacarbazine; Humans; Male; Oligodendroglioma; Retrospective Studies; Temozolomide	2004
Neuro-oncology: the growing role of chemotherapy in glioma. The Lancet. Neurology, 2005, Volume: 4, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Drug Resistance, Neoplasm; Gefitinib; Glioblastoma; Glioma; Humans; Meta-Analysis as Topic; Nitrosourea Compounds; Oligodendroglioma; Paraneoplastic Syndromes; Protein Kinase Inhibitors; Quinazolines; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Temozolomide	2005
Response of low-grade oligodendroglial tumors to temozolomide. Journal of neuro-oncology, 2004, Volume: 70, Issue:3 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chromosomes, Human, Pair 1; Controlled Clinical Trials as Topic; Dacarbazine; Humans; Loss of Heterozygosity; Oligodendroglioma; Temozolomide; Treatment Outcome	2004
Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature. Neuro-oncology, 2006, Volume: 8, Issue:3 Topics: Aged; Breast Neoplasms; Dacarbazine; Female; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Oligodendroglioma; Temozolomide	2006
Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? Critical reviews in oncology/hematology, 2006, Volume: 60, Issue:2 Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Oligodendroglioma; Salvage Therapy; Temozolomide; Tumor Suppressor Protein p14ARF; Tumor Suppressor Proteins	2006
[Pattern of care of high-grade gliomas]. La Revue du praticien, 2006, Oct-31, Volume: 56, Issue:16 Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Epilepsy; Forecasting; Genetic Markers; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Oligodendroglioma; Prognosis; Quality of Life; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Survival Analysis; Temozolomide; Thromboembolism; Time Factors; Tomography, X-Ray Computed	2006
Molecular targeted therapies and chemotherapy in malignant gliomas. Current opinion in oncology, 2007, Volume: 19, Issue:6 Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Dacarbazine; Disease-Free Survival; Glioma; Humans; Medical Oncology; Models, Biological; Neoplasm Metastasis; Oligodendroglioma; Signal Transduction; Temozolomide; Treatment Outcome	2007
[Recent advances in chemotherapy for malignant gliomas]. No shinkei geka. Neurological surgery, 2008, Volume: 36, Issue:2 Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Dacarbazine; DNA Repair; Glioma; Humans; Meta-Analysis as Topic; Oligodendroglioma; Randomized Controlled Trials as Topic; Temozolomide	2008
New chemotherapy options for the treatment of malignant gliomas. Current opinion in oncology, 1999, Volume: 11, Issue:3 Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Camptothecin; Clinical Trials as Topic; Dacarbazine; Enzyme Inhibitors; Glioma; Humans; Irinotecan; Neovascularization, Pathologic; Oligodendroglioma; Protease Inhibitors; Signal Transduction; Temozolomide; Thalidomide	1999
Chemotherapy for the treatment of oligodendroglial tumors. Seminars in oncology, 2001, Volume: 28, Issue:4 Suppl 13 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials as Topic; Dacarbazine; Humans; Lomustine; Oligodendroglioma; Procarbazine; Prognosis; Temozolomide; Vincristine	2001

Trials

17 trial(s) available for dacarbazine and Anaplastic Oligodendroglioma

Article	Year
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma. Neuro-oncology, 2017, Oct-01, Volume: 19, Issue:10 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; Disease-Free Survival; Female; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Oligodendroglioma; Stem Cell Transplantation; Temozolomide; Transplantation, Autologous	2017
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study. Journal of neuro-oncology, 2015, Volume: 122, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Oligodendroglioma; Patient Outcome Assessment; Prognosis; Quality of Life; Survival Rate; Temozolomide; Young Adult	2015
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131. Journal of neuro-oncology, 2015, Volume: 124, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Radiotherapy; Retrospective Studies; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2015
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131. Neuro-oncology, 2009, Volume: 11, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Astrocytoma; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Combined Modality Therapy; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Dose Fractionation, Radiation; Female; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Prognosis; Promoter Regions, Genetic; Survival Rate; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins; Young Adult	2009
Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma. Journal of neuro-oncology, 2009, Volume: 92, Issue:1 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Humans; Kaplan-Meier Estimate; Loss of Heterozygosity; Oligodendroglioma; Prognosis; Promoter Regions, Genetic; Temozolomide; Tumor Suppressor Proteins	2009
Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study. Neurosurgery, 2010, Volume: 66, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Cross-Linking Reagents; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Injections, Intra-Arterial; Lomustine; Male; Melphalan; Middle Aged; Oligodendroglioma; Osmotic Pressure; Procarbazine; Temozolomide; Vincristine; Young Adult	2010
A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors. Neuro-oncology, 2010, Volume: 12, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Gene Deletion; Humans; Kaplan-Meier Estimate; Loss of Heterozygosity; Male; Middle Aged; Oligodendroglioma; Temozolomide; Tumor Suppressor Proteins; Young Adult	2010
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma. Cancer, 2012, Oct-01, Volume: 118, Issue:19 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Benzamides; Brain Neoplasms; Cohort Studies; Dacarbazine; Diarrhea; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Hydroxyurea; Imatinib Mesylate; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oligodendroglioma; Piperazines; Pyrimidines; Temozolomide; Thrombocytopenia; Treatment Outcome	2012
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:4 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Temozolomide; Treatment Outcome; Vincristine	2003
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Jul-01, Volume: 21, Issue:13 Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Disease Progression; Drug Administration Schedule; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Temozolomide; Treatment Outcome	2003
Initial chemotherapy in gliomatosis cerebri. Neurology, 2004, Jul-27, Volume: 63, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Karnofsky Performance Status; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Neuroepithelial; Oligodendroglioma; Procarbazine; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine	2004
Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide. Neurology, 2004, Jul-27, Volume: 63, Issue:2 Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Life Tables; Male; Middle Aged; Neoplasms, Neuroepithelial; Oligodendroglioma; Prospective Studies; Temozolomide; Treatment Outcome	2004
Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas. Neurology, 2004, Sep-14, Volume: 63, Issue:5 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Cohort Studies; Dacarbazine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Remission Induction; Retrospective Studies; Salvage Therapy; Sequence Deletion; Temozolomide; Treatment Outcome; Vincristine	2004
Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial. Journal of neuro-oncology, 2006, Volume: 79, Issue:2 Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oligodendroglioma; Temozolomide; Treatment Outcome	2006
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Oct-10, Volume: 24, Issue:29 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; DNA Methylation; DNA Repair; Female; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged; Neoplasm Recurrence, Local; O(6)-Methylguanine-DNA Methyltransferase; Oligodendroglioma; Promoter Regions, Genetic; Temozolomide; Treatment Outcome	2006
CPT-11 for recurrent temozolomide-refractory 1p19q co-deleted anaplastic oligodendroglioma. Journal of neuro-oncology, 2008, Volume: 89, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Chromosome Deletion; Chromosomes, Human, Pair 1; Dacarbazine; Female; Humans; Irinotecan; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Survival Analysis; Temozolomide	2008
Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, May-01, Volume: 19, Issue:9 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Dacarbazine; Humans; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Temozolomide	2001

Other Studies

46 other study(ies) available for dacarbazine and Anaplastic Oligodendroglioma

Article	Year
Early results from the CODEL trial for anaplastic oligodendrogliomas: is temozolomide futile? Neuro-oncology, 2021, 03-25, Volume: 23, Issue:3 Topics: Brain Neoplasms; Dacarbazine; Humans; Oligodendroglioma; Temozolomide	2021
Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis. World neurosurgery, 2017, Volume: 103 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Disease Management; Female; Glioblastoma; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Neuroepithelial; Neurosurgical Procedures; Oligodendroglioma; Proportional Hazards Models; Retrospective Studies; SEER Program; Survival Rate; Temozolomide	2017
A case of glioblastoma resected immediately after administering bevacizumab: consideration on histopathological findings and safety of surgery. Brain tumor pathology, 2017, Volume: 34, Issue:2 Topics: Adult; Bevacizumab; Brain Neoplasms; Combined Modality Therapy; Craniotomy; Dacarbazine; Humans; Intracranial Thrombosis; Male; Oligodendroglioma; Radiotherapy; Temozolomide; Treatment Outcome; Venous Thrombosis	2017
Chemotherapy of Oligodendrogliomas. Progress in neurological surgery, 2018, Volume: 31 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Glioma; Humans; Oligodendroglioma; Temozolomide	2018
Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics. Neuropathology : official journal of the Japanese Society of Neuropathology, 2013, Volume: 33, Issue:6 Topics: Brain Neoplasms; Chemoradiotherapy; Child; Dacarbazine; Fatal Outcome; Glioblastoma; Humans; Male; Microsatellite Instability; Neoplasms, Complex and Mixed; Neurosurgical Procedures; Oligodendroglioma; Phenotype; Temozolomide	2013
Case of pediatric optic pathway oligodendroglioma presenting widespread invasion and dissemination in the cerebrospinal fluid. Brain tumor pathology, 2014, Volume: 31, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Child; Dacarbazine; Female; Humans; Magnetic Resonance Imaging; Neoplasm Invasiveness; Neurosurgical Procedures; Oligodendroglioma; Optic Nerve Neoplasms; Temozolomide; Treatment Outcome; Vincristine; Visual Pathways	2014
Extraneural metastases of anaplastic oligodendroglioma. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2014, Volume: 122, Issue:7 Topics: Antineoplastic Agents, Alkylating; Bone Neoplasms; Brain Neoplasms; Dacarbazine; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Temozolomide	2014
Experimental study of combined therapy for malignant glioma. Bulletin of experimental biology and medicine, 2014, Volume: 156, Issue:4 Topics: Animals; Animals, Outbred Strains; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Indoles; Neoplasm Transplantation; Nitrosourea Compounds; Oligodendroglioma; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Rats, Wistar; Temozolomide	2014
Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Sep-15, Volume: 20, Issue:18 Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents, Alkylating; Blotting, Western; Brain Neoplasms; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; Genotype; Glioblastoma; Humans; Male; Mice; Middle Aged; Mutation; Oligodendroglioma; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Temozolomide; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays; Young Adult	2014
Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV. Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:4 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Dacarbazine; Evidence-Based Medicine; Glioma; Humans; Lomustine; Neoplasm Grading; Neoplasm Staging; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine	2015
Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for temozolomide. Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:4 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Evidence-Based Medicine; Glioma; Humans; Lomustine; Neoplasm Grading; Neoplasm Staging; Oligodendroglioma; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine	2015
Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma? Clinical neurology and neurosurgery, 2015, Volume: 135 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Karnofsky Performance Status; Male; Middle Aged; Neoplasms, Complex and Mixed; Neurosurgical Procedures; Oligodendroglioma; Prognosis; Temozolomide; Treatment Outcome; Young Adult	2015
Spinal Anaplastic Oligodendroglioma With Oligodendrogliomatosis: Molecular Markers and Management: Case Report. Neurosurgery, 2016, Volume: 78, Issue:3 Topics: Aged; Antineoplastic Agents, Alkylating; Chemoradiotherapy; Dacarbazine; Humans; Magnetic Resonance Imaging; Male; Oligodendroglioma; Spinal Cord Neoplasms; Temozolomide	2016
Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of High-Grade Glioma. Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:10 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bevacizumab; Brain Neoplasms; Camptothecin; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Cyclophosphamide; Dacarbazine; Glioblastoma; Humans; Irinotecan; Lomustine; Neoplasm Grading; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Radiotherapy; Singapore; Temozolomide; Teniposide; Vincristine	2015
Temozolomide induces radiologic pseudoprogression and tumor cell vanishing in oligodendroglioma. Neurology, 2016, 07-05, Volume: 87, Issue:1 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Oligodendroglioma; Temozolomide	2016
Case 38-2016. A 52-Year-Old Woman with Recurrent Oligodendroglioma. The New England journal of medicine, 2016, 12-15, Volume: 375, Issue:24 Topics: Antineoplastic Agents, Alkylating; Biopsy; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Diagnosis, Differential; Female; Frontal Lobe; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Middle Aged; Mutation; Neoplasm Recurrence, Local; Oligodendroglioma; Temozolomide	2016
Quality of life in low-grade glioma patients receiving temozolomide. Neuro-oncology, 2009, Volume: 11, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Dacarbazine; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasm Staging; Oligodendroglioma; Outcome Assessment, Health Care; Prognosis; Prospective Studies; Quality of Life; Sickness Impact Profile; Temozolomide; Treatment Outcome; Young Adult	2009
Efficacy of temozolomide treatment in patients with high-grade glioma. Anticancer research, 2009, Volume: 29, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Etoposide; Female; Glioblastoma; Gliosarcoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Prognosis; Temozolomide; Treatment Outcome; Tumor Necrosis Factor-alpha	2009
Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide. Journal of the neurological sciences, 2009, Dec-15, Volume: 287, Issue:1-2 Topics: Antineoplastic Agents, Alkylating; Arachnoid; Brain; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; DNA Mutational Analysis; Gene Deletion; Genetic Predisposition to Disease; Genotype; Humans; Magnetic Resonance Imaging; Male; Meningeal Carcinomatosis; Meningeal Neoplasms; Middle Aged; Mutation; Neoplasm Metastasis; Oligodendroglioma; Pia Mater; Radiotherapy; Spinal Cord; Subarachnoid Space; Temozolomide; Treatment Outcome	2009
Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection. Neurosurgical review, 2010, Volume: 33, Issue:1 Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Child; Dacarbazine; Databases, Factual; Disease Progression; Female; Follow-Up Studies; Glioma; Humans; Kinetics; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neurosurgical Procedures; Oligodendroglioma; Retrospective Studies; Temozolomide; Young Adult	2010
Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination. Journal of neuro-oncology, 2010, Volume: 97, Issue:3 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cytarabine; Dacarbazine; Humans; Injections, Spinal; Liposomes; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Oligodendroglioma; Temozolomide	2010
Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells. Neoplasia (New York, N.Y.), 2010, Volume: 12, Issue:1 Topics: Amino Acids; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Female; Gene Expression Regulation, Neoplastic; Genomics; HT29 Cells; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplastic Stem Cells; Oligodendroglioma; Proteomics; Reverse Transcriptase Polymerase Chain Reaction; Temozolomide; Time Factors; Xenograft Model Antitumor Assays	2010
Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma. Journal of neuro-oncology, 2011, Volume: 101, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; DNA, Neoplasm; Female; Follow-Up Studies; Humans; Male; Oligodendroglioma; Polymerase Chain Reaction; Promoter Regions, Genetic; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins	2011
Non-stem cell origin for oligodendroglioma. Cancer cell, 2010, Dec-14, Volume: 18, Issue:6 Topics: Animals; Antigens; Benzamides; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Dacarbazine; Diphenylamine; Humans; Mice; Mitogen-Activated Protein Kinases; Neural Stem Cells; Oligodendroglia; Oligodendroglioma; Oncogene Proteins v-erbB; Proteoglycans; Temozolomide; Tumor Suppressor Protein p53	2010
Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide. Journal of neuro-oncology, 2011, Volume: 104, Issue:1 Topics: Adolescent; Antineoplastic Agents, Alkylating; Chromosome Deletion; Chromosomes, Human, Pair 1; Dacarbazine; Female; Humans; Oligodendroglioma; Spinal Cord Neoplasms; Temozolomide	2011
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro-oncology, 2011, Volume: 13, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, Human, Pair 1; Cohort Studies; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Follow-Up Studies; Humans; International Agencies; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Radiotherapy; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Vincristine; Young Adult	2011
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial. Acta neuropathologica, 2012, Volume: 123, Issue:6 Topics: Adolescent; Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Clinical Trials, Phase III as Topic; Dacarbazine; DNA Methylation; ErbB Receptors; Female; Glioblastoma; Humans; Male; Middle Aged; Mutation; Oligodendroglioma; Prognosis; Survival Analysis; Temozolomide; Treatment Outcome; Young Adult	2012
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology). Neuro-oncology, 2012, Volume: 14, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oligodendroglioma; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Young Adult	2012
Initial treatment patterns over time for anaplastic oligodendroglial tumors. Neuro-oncology, 2012, Volume: 14, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; Female; Follow-Up Studies; Gene Deletion; Humans; International Agencies; Male; Middle Aged; Oligodendroglioma; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Young Adult	2012
IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy. Brain tumor pathology, 2013, Volume: 30, Issue:2 Topics: Adult; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Glioblastoma; Humans; Mutation; Neoplasms, Multiple Primary; Oligodendroglioma; Radiotherapy; Retrospective Studies; Second-Look Surgery; Temozolomide	2013
Decision making and management of gliomas: practical considerations. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23 Suppl 10 Topics: Aged; Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Glioblastoma; Humans; Isocitrate Dehydrogenase; Meta-Analysis as Topic; Oligodendroglioma; Temozolomide; Tumor Suppressor Proteins	2012
Sarcomatous evolution of oligodendroglioma ("oligosarcoma"): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors. Pathology, research and practice, 2012, Dec-15, Volume: 208, Issue:12 Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Combined Modality Therapy; Dacarbazine; Disease Progression; Gliosarcoma; Humans; Isocitrate Dehydrogenase; Male; Mutation; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Oligodendroglioma; Temozolomide	2012
Breast metastasis of anaplastic oligodendroglioma: a case report. Tumori, 2012, Volume: 98, Issue:6 Topics: Antineoplastic Agents, Alkylating; Aphasia; Brain Neoplasms; Breast Neoplasms, Male; Chemoradiotherapy, Adjuvant; Dacarbazine; Disease Progression; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Mammography; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Temozolomide	2012
Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology, 2003, Mar-11, Volume: 60, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Ependymoma; Female; Glioblastoma; Glioma; Humans; Image Enhancement; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Paclitaxel; Procarbazine; Sensitivity and Specificity; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Vincristine	2003
Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results. Journal of neuro-oncology, 2003, Volume: 61, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chromosomes, Human, Pair 1; Dacarbazine; Data Interpretation, Statistical; Female; Humans; Loss of Heterozygosity; Male; Middle Aged; Oligodendroglioma; Retrospective Studies; Temozolomide; Treatment Outcome	2003
Survival of patients with recurrent malignant glioma treated with temozolomide: a retrospective observational study. Drugs in R&D, 2003, Volume: 4, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Astrocytoma; Central Nervous System Neoplasms; Clinical Trials as Topic; Dacarbazine; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Retrospective Studies; Survival Analysis; Temozolomide; Time Factors; Treatment Outcome	2003
Long-term outcome of oligodendrogliomas. Neurology, 2004, May-25, Volume: 62, Issue:10 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dacarbazine; Epilepsies, Partial; Etoposide; Female; Follow-Up Studies; Humans; Life Tables; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Nitrosourea Compounds; Oligodendroglioma; Organophosphorus Compounds; Procarbazine; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi; Temozolomide; Treatment Outcome; Vincristine	2004
Distinct responses of xenografted gliomas to different alkylating agents are related to histology and genetic alterations. Cancer research, 2004, Jul-01, Volume: 64, Issue:13 Topics: Animals; Antineoplastic Agents, Alkylating; Carboplatin; Carmustine; Chromosome Aberrations; Dacarbazine; Glioblastoma; Humans; Ifosfamide; Loss of Heterozygosity; Mice; Mice, Nude; Mutation; Oligodendroglioma; Temozolomide; Xenograft Model Antitumor Assays	2004
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Aug-01, Volume: 22, Issue:15 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Dacarbazine; Female; Humans; Loss of Heterozygosity; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Temozolomide	2004
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. International journal of radiation oncology, biology, physics, 2005, Oct-01, Volume: 63, Issue:2 Topics: Adult; Aged; alpha-Methyltyrosine; Analysis of Variance; Antineoplastic Agents, Alkylating; Astrocytoma; Combined Modality Therapy; Dacarbazine; Dose Fractionation, Radiation; Female; Glioblastoma; Glioma; Gliosarcoma; Humans; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Positron-Emission Tomography; Prospective Studies; Statistics, Nonparametric; Stereotaxic Techniques; Temozolomide; Tomography, Emission-Computed, Single-Photon	2005
Salvage temozolomide for prior temozolomide responders. Cancer, 2005, Dec-01, Volume: 104, Issue:11 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Dacarbazine; Female; Glioblastoma; Humans; Male; Middle Aged; Oligodendroglioma; Recurrence; Retrospective Studies; Salvage Therapy; Survival Analysis; Temozolomide	2005
Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression. Cancer, 2006, Apr-15, Volume: 106, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dacarbazine; Disease Progression; DNA Repair; Female; Humans; Immunohistochemistry; Loss of Heterozygosity; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Oligodendroglioma; Temozolomide	2006
Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma. Epilepsia, 2006, Volume: 47, Issue:7 Topics: Adult; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Comorbidity; Dacarbazine; Drug Resistance; Epilepsy; Humans; Magnetic Resonance Imaging; Male; Oligodendroglioma; Temozolomide; Treatment Outcome	2006
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:15 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Clinical Trials, Phase II as Topic; Dacarbazine; Disease-Free Survival; Humans; In Situ Hybridization, Fluorescence; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Oligodendroglioma; Prospective Studies; Salvage Therapy; Survival Analysis; Temozolomide; Treatment Outcome	2006
Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide. Anti-cancer drugs, 1999, Volume: 10, Issue:2 Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Dacarbazine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Glioblastoma; Humans; Inhibitory Concentration 50; Lomustine; Oligodendroglioma; Temozolomide; Tumor Cells, Cultured	1999
Temozolomide chemotherapy in recurrent oligodendroglioma. Neurology, 2001, Jul-24, Volume: 57, Issue:2 Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Humans; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Temozolomide; Time Factors	2001